Key result
Conservative medical therapy including colchicine, steroids, and integrase inhibitors successfully resolved COVID-19-induced moderate pericardial effusion with early signs of cardiac tamponade.
Why the study?
COVID-19 presentation is heterogeneous, and as a viral illness it could cause pericardial effusion leading to cardiac tamponade.
Case Report (n=1)
Early diagnosis and conservative management with anti-inflammatories, steroids, and integrase inhibitors can effectively treat COVID-19-induced cardiac tamponade without the need for invasive procedures.
Answers are grounded in this paper and cite their sources.
Raises awareness for tamponade in COVID-19; leaves open its prevalence and management implications pending larger studies.
COVID-19 presentation is heterogeneous. As a viral illness, it could cause pericardial effusion leading to cardiac tamponade. We present a patient coursing with this viral illness that was found to have cardiac tamponade. We report a case of a 79-year-old female who presented with shortness of breath and dry cough for one week and resulted positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Her initial chest X-ray showed a bottle-shaped heart. Computed chest tomography showed pericardial effusion, and an echocardiogram confirmed moderated pericardial effusion with signs of tamponade. He improved with conservative therapy with colchicine, ibuprofen, cefepime, dexamethasone, dolutegravir, and apixaban for pulmonary emboli. An early approach in cardiac tamponade induced by COVID-19 is crucial to promptly address an aggressive directed therapy, avoiding potential complications or unnecessary procedures.
No takes yet. Share an insight, caveat, or question.
Mishra et al. (2023) conducted a case report in COVID-19-induced cardiac tamponade (n=1). Conservative medical therapy (colchicine, ibuprofen, cefepime, dexamethasone, dolutegravir, apixaban) was evaluated on Resolution of pericardial effusion and tamponade. Conservative medical therapy including colchicine, steroids, and integrase inhibitors successfully resolved COVID-19-induced moderate pericardial effusion with early signs of cardiac tamponade.
Synapse has enriched 10 related papers. Consider them for comparative context: